Rivastigmine Tartrate [129101-54-8]

Moriguchi S, Tagashira H, Sasaki Y, et al. CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment. J Neurochem. 2013 Oct 28. [Epub ahead of print]. PMID: 24164423. Bailey JA, Ray B, Greig NH, et al. Rivastigmine lowers Abèta and increases sAPPalfa levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons. PLoS One. 2011;6(7):e21954. PMID: 21799757. Pollak Y, Gilboa A, Ben-Menachem O, et al. Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production. Ann Neurol. 2005 May;57(5):741-5. PMID: 15852394. Krall WJ, Sramek JJ, Cutler NR. Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Ann Pharmacother. 1999 Apr;33(4):441-50. PMID: 10332536.